Protein turnover downstream of the Nipbl/CRL4 axis contributes to abnormal development in zebrafish embryos

Annie C Sanchez1, Niusha Banoukh1, Fiona Mensching1

  • 1Department of Biological Sciences, Lehigh University, Bethlehem, Pennsylvania, USA.

Abstract

Insights

NIPBL regulates the CRL4 E3 ligase by controlling ddb1 expression, impacting cohesinopathies like Cornelia de Lange Syndrome. Aberrant substrate accumulation causes developmental abnormalities.

Area of Science:

  • Genetics
  • Molecular Biology
  • Developmental Biology

Background:

  • Cohesinopathies, including Cornelia de Lange Syndrome (CdLS) and Roberts Syndrome (RBS), arise from mutations in cohesins.
  • Esco2 and Smc3 are known regulators of the CRL4 E3 ubiquitin ligase.
  • SMC3 mutations are infrequent in CdLS, prompting investigation into other key genes like NIPBL.

Purpose of the Study:

  • To investigate whether NIPBL, a gene frequently mutated in CdLS, also regulates the CRL4 E3 ubiquitin ligase.
  • To elucidate the mechanism by which NIPBL influences CRL4 ligase activity and its downstream consequences.

Main Methods:

  • Zebrafish embryos were used to study the effects of Nipbl knockdown.
  • Quantitative analysis of ddb1 transcription was performed.
  • Rescue experiments with exogenous ddb1 mRNA were conducted.
  • Liquid chromatography-mass spectrometry (LC-MS) was employed to identify CRL4 substrates.

Main Results:

  • Nipbl knockdown in zebrafish caused developmental abnormalities and reduced ddb1 transcription.
  • Exogenous ddb1 mRNA partially rescued the phenotypes, confirming CRL4 ligase function downstream of Nipbl.
  • Elevated expression of the identified CRL4 substrate candidate, pparαa, was sufficient to induce developmental defects.

Conclusions:

  • Nipbl regulates CRL4 ligase activity through modulation of ddb1 expression.
  • Aberrant accumulation of CRL4 substrates contributes to developmental abnormalities seen in cohesinopathies.
  • These findings provide a mechanistic link between NIPBL function and CRL4 ligase activity in the context of CdLS and RBS.